Long-acting and short-acting benzodiazepines in the elderly: Kinetic differences and clinical relevance

R. Bandera, P. Bollini, S. Garattini

Research output: Contribution to journalArticlepeer-review


A review of available information about the pharmacokinetics of pro-nor-diazepam-like compounds in the elderly shows substantial impairment of the metabolism compared to oxazepam-like benzodiazepines, which are metabolized with virtually no change in this age group. Results of clinical trials point in the same direction, although small numbers of patients, different criteria for measuring clinical benefit and adverse reactions and different dosages for various periods of time make the comparison difficult. Qualified clinical guidelines are mainly to reduce dosage and use oxazepam-like compounds in the elderly, but routine clinical practice does not seem to apply these recommendations. Further research is therefore needed, mainly in the area of clinical practice, to describe the 'real' situation of benzodiazepine prescription for in-patients and out-patients in terms of risk-benefit ratio of drug treatment and to monitor the changes occurring when a more rational approach is introduced as regards the need for treatment, dose and duration of treatment.

Original languageEnglish
Pages (from-to)94-107
Number of pages14
JournalCurrent Medical Research and Opinion
Issue numbers4
Publication statusPublished - 1984


  • Aged
  • Benzodiazepines
  • Pharmacokinetics

ASJC Scopus subject areas

  • Medicine(all)


Dive into the research topics of 'Long-acting and short-acting benzodiazepines in the elderly: Kinetic differences and clinical relevance'. Together they form a unique fingerprint.

Cite this